Clinical trials
Completed Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
621 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 12 |
| 2001 | 18 |
| 2002 | 16 |
| 2003 | 15 |
| 2004 | 13 |
| 2005 | 31 |
| 2006 | 24 |
| 2007 | 26 |
| 2008 | 24 |
| 2009 | 30 |
| 2010 | 35 |
| 2011 | 24 |
| 2012 | 28 |
| 2013 | 18 |
| 2014 | 33 |
| 2015 | 26 |
| 2016 | 32 |
| 2017 | 40 |
| 2018 | 32 |
| 2019 | 25 |
| 2020 | 15 |
| 2021 | 16 |
| 2022 | 19 |
| 2023 | 4 |
| 2024 | 9 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 621 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 44 |
| Duke University | 39 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 18 |
| Memorial Sloan Kettering Cancer Center | 15 |
| Dana-Farber Cancer Institute | 9 |
| Mayo Clinic | 9 |
| Wake Forest University Health Sciences | 9 |
| Case Comprehensive Cancer Center | 8 |
| City of Hope Medical Center | 8 |
| M.D. Anderson Cancer Center | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 621 |
| Glioblastoma | 309 |
| Brain Neoplasms | 275 |
| Astrocytoma | 217 |
| Oligodendroglioma | 160 |
| Gliosarcoma | 141 |
| Central Nervous System Neoplasms | 119 |
| Ependymoma | 78 |
| Medulloblastoma | 57 |
| Neoplasms | 41 |
Trials
Showing 1 to 25 of 621. Each trial links to its page on Pharma Observatory.
521 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.